Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.

@article{Berger2006AspirinFT,
  title={Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials.},
  author={Jeffrey S Berger and Maria Carla Roncaglioni and Fausto Avanzini and Ierta Pangrazzi and Gianni Tognoni and David L Brown},
  journal={JAMA},
  year={2006},
  volume={295 3},
  pages={
          306-13
        }
}
  • Jeffrey S Berger, Maria Carla Roncaglioni, +3 authors David L Brown
  • Published 2006
  • Medicine
  • JAMA
  • CONTEXT Aspirin therapy reduces the risk of cardiovascular disease in adults who are at increased risk. However, it is unclear if women derive the same benefit as men. OBJECTIVE To determine if the benefits and risks of aspirin treatment in the primary prevention of cardiovascular disease vary by sex. DATA SOURCES AND STUDY SELECTION MEDLINE and the Cochrane Central Register of Controlled Trials databases (1966 to March 2005), bibliographies of retrieved trials, and reports presented at… CONTINUE READING

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    The proposed study will add to the growing understanding of platelet activity and platelet inhibition in subjects with HIV. It will examine the relationship between platelet activity… Expand
    ConditionsCardiovascular Diseases, HIV, Inflammation
    InterventionDrug

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 371 CITATIONS, ESTIMATED 45% COVERAGE

    FILTER CITATIONS BY YEAR

    2006
    2020

    CITATION STATISTICS

    • 5 Highly Influenced Citations

    • Averaged 19 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 27 REFERENCES